Life Sciences Academy | Data Privacy and Governance for use of AI in Life Sciences and Healthcare

AI is revolutionising the Life Sciences and Healthcare (LSH) sector, enabling companies to harness large datasets to accelerate drug discovery, optimise clinical trials with artificial patients, and enhance patient care treatments. However, the development, training, and utilisation of AI systems in the LSH sector involve processing highly sensitive health data, which triggers stringent requirements under EU and UK data protection law. Additionally, ethical considerations are paramount in establishing an AI governance framework specific to the LSH sector.

Join our panel and guest speaker Donovan Sheppard (Global Senior Counsel, Data Privacy, UCB) as we explore the delicate balance (or lack thereof) between regulation and innovation. Gain practical insights from experts in the UK and EU (Germany, Belgium, and France) on privacy law requirements, potential solutions through anonymisation or synthetic health data, opportunities for AI via the European Health Data Space (EHDS), and the ethical dimensions of AI in healthcare.